[go: up one dir, main page]

UA97450U - Method of fetal neuroprotection - Google Patents

Method of fetal neuroprotection

Info

Publication number
UA97450U
UA97450U UAU201411784U UAU201411784U UA97450U UA 97450 U UA97450 U UA 97450U UA U201411784 U UAU201411784 U UA U201411784U UA U201411784 U UAU201411784 U UA U201411784U UA 97450 U UA97450 U UA 97450U
Authority
UA
Ukraine
Prior art keywords
solution
neuroprotection
infusion
diluted
rate
Prior art date
Application number
UAU201411784U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Iryna Borysivna Ventskivska
Viktoriia Volodymyrivna Bila
Serhii Stanislavovych Leush
Nataliia Mykolaivna Kolesnyk
Oleksanda Serhiivna Zahorodnia
Original Assignee
Univ Bohomolets Nat Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bohomolets Nat Medical filed Critical Univ Bohomolets Nat Medical
Priority to UAU201411784U priority Critical patent/UA97450U/en
Publication of UA97450U publication Critical patent/UA97450U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Спосіб нейропротекції плода включає застосування лікарських засобів, причому додатково на тлі традиційної схеми лікування призначають магнезіальну терапію за схемою: сухої речовини магнію сульфату вводять внутрішньовенно протягом 1 години, для цього 16 мл 25 % розчину розводять 200 мл фізіологічного розчину натрію хлориду, в подальшому тривала інфузія сульфату магнію із швидкістю сухої речовини в годину протягом 4 годин, для цього 16 мл 25 % розчину розводять 400 мл фізіологічного розчину та вводять зі швидкістю 100 мл за годину, інфузію припиняють з початком потужного періоду пологів.The method of neuroprotection of the fetus involves the use of medicines, and additionally on the background of the traditional treatment regimen, prescribe magnesium therapy according to the scheme: magnesium sulfate dry matter is administered intravenously for 1 hour, for this purpose 16 ml of 25% solution is diluted with 200 ml of physiological sodium chloride solution, followed by infusion magnesium sulfate at a rate of dry matter per hour for 4 hours, for this 16 ml of 25% solution is diluted with 400 ml of saline and administered at a rate of 100 ml per hour, infusion is stopped tion with the beginning of a powerful stage of labor.

UAU201411784U 2014-10-31 2014-10-31 Method of fetal neuroprotection UA97450U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201411784U UA97450U (en) 2014-10-31 2014-10-31 Method of fetal neuroprotection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201411784U UA97450U (en) 2014-10-31 2014-10-31 Method of fetal neuroprotection

Publications (1)

Publication Number Publication Date
UA97450U true UA97450U (en) 2015-03-10

Family

ID=52990613

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201411784U UA97450U (en) 2014-10-31 2014-10-31 Method of fetal neuroprotection

Country Status (1)

Country Link
UA (1) UA97450U (en)

Similar Documents

Publication Publication Date Title
MX2022015499A (en) Methods of treating crohn's disease and ulcerative colitis.
MX2017003780A (en) PHARMACEUTICAL COMPOSITION TO TREAT ULCERATIVE COLITIS.
PH12017500747B1 (en) Heterocyclic compound
ZA201704327B (en) Methods and compositions for treating brain diseases
PH12018501237A1 (en) Isoindole compounds
EA201891007A1 (en) AIMING FOR FORMILPEPTID RECEPTOR 2 / LIPOXIN A RECEPTOR (FPR2 / ALX) FOR TREATING HEART DISEASES
MX2016013611A (en) Use of ctla4 compound for achieving drug-free remission in subjects with early ra.
MX2016014346A (en) Treatment of crohn's disease with delayed-release 6-mercaptopurine.
MX2017009325A (en) Levodopa and carbidopa intestinal gel and methods of use.
CA2971512C (en) METHOD FOR TREATING HEART FAILURE
NZ720273A (en) Preparations and methods for treating a gd2 positive cancer
MX2017015664A (en) Intravenous administration of citrulline during surgery.
EA201790991A1 (en) METHOD OF TREATMENT USING A PEGILATED INTERFERON
EA201500765A1 (en) METHODS OF TREATING CARDIOVASCULAR DISEASES
MD20180049A2 (en) Pharmaceutical composition
UA97450U (en) Method of fetal neuroprotection
RU2014106575A (en) METHOD FOR PREVENTION OF BLEEDING WITH MYOMECTOMY
MD4317B1 (en) Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure
UA81941U (en) Method for treating chronic endometritis at stage of preconception preparation
RU2012115039A (en) METHOD FOR TREATING CHRONIC ENDOMETRITIS
UA92439U (en) Method for treating ischemic heart disease in patients with community-acquired pneumonia
UA99842U (en) The method of anesthesia
Yu Giant inverted T waves and substantial QT interval prolongation: case report
UA82717U (en) Method for treatment of acute ischemic stroke, burdened with ischemic heart disease
NZ624360A (en) Methods of reducing milk somatic cell count